Introduction
Radiation therapy is one of the major nonsurgical cancer treatments by targeting the integrity of cellular DNA. DNA double-strand breaks (DSBs) are the most important DNA lesions leading to cancer cell death following exposure to ionizing radiation (IR) (Khanna and Jackson, 2001 ). However, an elevated DNA-repair capacity in tumor cells lead to radiation resistance and severely limits the efficacy of IR, and the balance between DNA damage and repair determines the final therapeutic consequences (Ding et al., 2006) .
Mre11 is a DNA binding protein that possesses 3 0 ,5 0 -exonuclease activity, as well as an endonuclease activity that cleaves DNA hairpins (Paull and Gellert, 1998; Borde and Cobb, 2009) . Inherited mutations in the Mre11A are responsible for the cancer-prone syndromes ataxia telangiectasia-like disorder (Stewart et al., 1999) . Mre11 is the central protein-nucleic and protein-protein interaction nucleus of the complex that binds RAD50, NBS1 and DNA. It has been proven that Mre11/Rad50/ Nbs1 complex (MRN) is required for the maintenance of genome stability during DNA replication, for telomere length maintenance and for DNA repair (Haber, 1998; Costanzo et al., 2001; Wu et al., 2007; Deng et al., 2009) . After IR occurs, the MRN complex rapidly associates in foci at the site of DNA-DSBs, remaining at the sites until the damage has been repaired (Nelms et al., 1998) .
Protein kinase B/Akt kinase, a serine/threonine kinase, is the core component of the phosphoinositide 3-kinase/Akt signaling pathway, which is one of the most frequently hyperactivated signaling pathways in human cancers. Once activated, Akt can translocate from cellular-membrane into cytoplasm and nucleus and phosphorylate numerous proteins, leading to tumor development or progression, as well as resistance to treatment with chemotherapy and/or radiation therapy (Bellacosa et al., 2005) . GSK-3b is one of the important target genes of Akt (Cross et al., 1995) . It has been reported that GSK-3b can not only regulate cyclin D1 proteolysis and subcellular localization (Diehl et al., 1998) , but also mediate the degradation of b-catenin molecules. Cytoplasmic b-catenin binds to the protein complex formed by axin, APC, GSK-3b and CK1a. Also cytoplasmic b-catenin is always phosphorylated by GSK-3b and CK1a, resulting in the degradation by the ubiquitin-proteasome system. However, b-catenin can escape from phosphorylation when GSK-3b is phosphorylated and inactivated by Akt. Then unphosphorylated-bcatenin accumulates in the cytoplasm and translocates to the nucleus, where it can complex with transcription factor LEF-1 and regulate the expression of specific genes (Morin et al., 1997; Shtutman et al., 1999; Takahashi-Yanaga and Sasaguri, 2007) .
Data from numerous investigators show that an elevated level of Akt activity was associated with increased cellular resistance to radiation therapy (Brognard et al., 2001; Kim et al., 2006) . Inhibition of phosphoinositide 3-kinase/Akt pathway leads to radiosensitization, such as glioblastomas, carcinoma of the breast, colon, bladder, prostate, head and neck and cervix (Gupta et al., 2002; Li et al., 2004; Altomare and Testa, 2005; Kim et al., 2005; Lee et al., 2006; Kao et al., 2007) . One of the important reason is that activated Akt promotes survival of cells exposed to IR through inhibition of apoptosis (Brognard et al., 2001) . In recent studies, it was reported that phosphoinositide 3-kinase/ Akt pathway may modulate DNA repair to affect the efficacy of radiation therapy (Tran et al., 2002; Kao et al., 2007; Toulany et al., 2008) . But the precise mechanism by which Akt activation regulates repair of DNA damage remains to be determined. In this report, we used human cancer cell lines CNE2 and HeLa to investigate the important roles of Akt and Mre11 in the repair of radiation-induced DNA-DSB damage. Our results showed that PKB/Akt activity affected the ability of tumor cells to repair the radiation-induced DNA-DSB damage. Knockdown of Mre11 also obviously impaired the process of DSB repair in both these two cell lines. More important, we found that Akt could regulate Mre11 expression, and GSK3b/b-catenin/LEF-1 pathway was involved in this regulation. These results together support that activated Akt can upregulate the expression of Mre11 through GSK3b/b-catenin/LEF pathway to elevate DSB-repair capacity, providing new insight into studying the mechanisms of activated Akt leading to resistance to radiotherapy.
Results
PKB/Akt activity affected the ability of tumor cells to repair the radiation-induced DNA-DSB damage To investigate the role of Akt in the the repair of radiation-induced DNA-DSB damage, retroviral vectors encoding short hairpin RNA (shRNA) sequences against Akt1 were stably transfected to CNE2 cells (exhibiting relatively high endogenous Akt activity), and the downregulation of phospho-Akt and Akt1 was at least 75% ( Figure 1a ). Then we investigated whether Akt might modulate unrepaired DNA-DSB damage. g-H2AX, phosphorylation of the Ser residue (Ser139), usually appears rapidly and is recruited to megabase domains detectable as nuclear foci after exposure of cells to IR, which represents the sites of unrepaired DSBs. The number of g-H2AX correlates with the amount of unrepaired damage (Celeste et al., 2002; Aten et al., 2004; Kao et al., 2007) , and a strong correlation between g-H2AX and cell death has been reported (Banath and Olive, 2003) . Thus, g-H2AX foci assay has been regarded as a sensitive and specific assay for unrepaired DSBs (Taneja et al., 2004; Bao et al., 2006; Kao et al., 2007; Toulany et al., 2008) . However, this also can lead to extra DSBs when the cells progress into S phase. So we analyzed the cell cycle phase of cancer cells at different times after IR. There was a minimal change in the percentage of cells in different phase after IR between the compared groups (Supplementary Figure  S1) . Therefore, we used g-H2AX foci assay to detect the unrepaired DSBs in this study. Figure 1c showed representative photographs of the CNE2/vector and the CNE2/Akt1 shRNA cells treated with IR (4Gy). Radiation-induced g-H2AX foci were readily visible. At 30 min, 94% of CNE2/vector and 95% of CNE2/Akt1 shRNA cells retained g-H2AX foci. But thereafter the number of cells with foci decreased, and the residual g-H2AX foci in CNE2/Akt1 shRNA cells were much higher than that in CNE2/vector cells. At 12 h, foci remained in 72% of CNE2/vector but were persisted in 81.4% of CNE2/Akt1 shRNA. After 24 h, the number of CNE2/vector with foci dropped to 33.76%, whereas CNE2/Akt1 shRNA remained at 54.46% (Po0.05). Then we further investigated whether direct AKT targeting affects the cellular resistance to radiationinduced DNA-DSB damage using clonogenic survival assay. As shown in Figure 1b , inhibition of Akt activity increased their sensitivity to radiation. Thus, it could be postulated that inhibition of Akt activity impaired the repair of radiation-induced DNA-DSB damage.
To explore the effect of activation of Akt on the repair of radiation-induced DNA-DSB damage, we transfected the HeLa cells (exhibiting relatively low endogenous Akt activity) with myr-Akt1 plasmid (constitutively activated Akt1), and selected the positive clones using G418 (Figure 1d ). Then HeLa/vector and HeLa/myr-Akt1 cells were treated with IR (2Gy). Radiation-induced g-H2AX foci were readily visible within 30 min of irradiation in these two cell lines. Then thereafter these foci had substantially decreased in number, but the residual g-H2AX foci in HeLa/vector cells were much higher than that in HeLa/myr-Akt1 cells. At 24 h, the rate of positive g-H2AX foci cells was 18.1% in HeLa/ myr-Akt1 cells, but was 29.6% in HeLa/vector cells (Po0.05) (Figure 1f ). Also clonogenic survival assays showed enhancement of Akt activity increased their resistance to radiation (Figure 1e ). Thus, it could be postulated that activated Akt promoted the repair of radiation-induced DNA-DSB damage.
Knockdown of Mre11 impaired the repair of radiationinduced DNA-DSB damage It has been proved that Mre11 protein is involved in the repair of DSB, as part of a complex of proteins, which includes the Rad50 and Nbs1 proteins. To further demonstrate the important roles of Mre11 involving in the process of the repair of radiation-induced DNA-DSB damage in cancer cells, CNE2 cells stably expressing Mre11 shRNA were selected using puromycine, and decreased expression level of Mre11 in cells was confirmed by western blot (Figure 2a ). Then g-H2AX assay was used to detect the unrepaired DSBs. Nearly all cells retained g-H2AX foci after irradiation (2 Gy) within 30 min. Thereafter the number of cells with foci decreased, but the residual g-H2AX foci in CNE2 cells with Mre11 knockdown were much higher than that in control cells. At 12 h, the number of g-H2AX-positive cells in control group dropped to 57.87%, whereas in CNE2/Mre11 shRNA group remained at 71.38%. And after 24 h, foci persisted in only 20.5% of CNE2/vector but were retained in 32.74% of CNE2/Mre11 shRNA (Po0.05) (Figure 2c ). Clonogenic survival assays also showed inhibition of 
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Mre11 expression increased their sensitivity to radiation ( Figure 2b ). Moreover, the protein level of g-H2AX was much higher in HeLa cells with Mre11 knockdown than that in control cells after 48 h following the cells treated with 1Gy irradiation (Figure 2d ). Taken together, the results clearly supported the idea that knockdown of Mre11 did impair the repair of radiation-induced DNA-DSB damage in cancer cells.
PKB/Akt upregulated Mre11 expression in cancer cells
Mre11 is an important member of DNA-DSB repair complex. Hence the question arises whether there did exist a correlation between Akt and Mre11. Therefore, the relationship between Akt and Mre11 was examined. Figure 3a showed that transient transfection with 25 nM small interfering RNA (siRNA) efficiently led to the downregulation of Akt expression at least 50%. More importantly, siRNA-directed knockdown of Akt1 led to inhibition of the endogenous Mre11 expression, as well as the levels of phospho-Akt. Also, the levels of Mre11 expression decreased dramatically when the cells were treated with different concentrations of LY294002 (a phosphoinositide 3-kinase inhibitor) for 24 h ( Figure 3b ). These data indicated that inhibition of Akt repressed endogenous Mre11 expression. Furthermore, we detected whether activation of Akt would be required for Mre11 expression. In comparison with the control cells (HeLa cells transfected with the vector plasmid), the exogenous Akt and phospho-Akt expression significantly increased in HeLa/myr-Akt1 cells ( Figure 3c ). Accordingly, the Mre11 messenger RNA (mRNA) and protein expression upregulated as demonstrated by western blot and RT-PCR analysis (Figure 3c ). To further confirm the transcriptional relationship between Akt1 and Mre11, CNE2 and HeLa cells were co-transfected with Mre11-dependent luciferase reporter Akt promotes DSB repair through regulating Mre11 expression R Deng et al (pGL3-Mre11) and with an empty vector/activated myrAkt1 plasmid. Subsequently, cell extracts were prepared and luciferase activity was measured. As shown in Figure 3e , Mre11 reporter activity increased after transfection with myr-Akt1 plasmids, and this Akt1-induced transcriptional activity was blocked in the presence of LY294002. Together, these findings indicated that activation of Akt upregulated the expression level of Mre11.
PKB/Akt might regulate the expression of Mre11 through GSK3b/b-catenin/LEF-1 pathway The results described above suggested that Akt could regulate Mre11 expression. However, which downstream signal pathways involved in this regulation are unknown. GSK3b/b-catenin pathway is one of the important downstream pathways of Akt. In addition, we used Transcription Element Search System to predict transcription factor binding sites in Mre11 DNA Akt promotes DSB repair through regulating Mre11 expression R Deng et al sequences, and the result showed the possibility of LEF-1-binding sequences in Mre11 promoter. Therefore we proposed that Akt might regulate the expression of Mre11 through GSK3b/b-catenin/LEF-1 pathway. As expected, the levels of phospho-GSK3b and b-catenin decreased when the activity of Akt was inhibited by LY294002 in CNE2 cells (Figure 4a ), and the levels of phospho-GSK3b and b-catenin increased when constitutively activated Akt1 was overexpressed in HeLa cells (Figure 4b ). These results demonstrated that Akt might regulate b-catenin/LEF-1 pathway through GSK3b in these cell models. We further confirmed the relationship between b-catenin and Mre11. A siRNA directed against the sequence of b-catenin or a plasmid encoding b-catenin was transfected to cancer cells to knockdown or enhance b-catenin expression, respectively. It was found that knockdown of b-catenin led to the downregulation of Mre11 (Figure 5a ), whereas overexpression of b-catenin led to the upregulation of Mre11 expression at the mRNA and protein levels (Figure 5b ). And knockdown of LEF1 by siRNA led to the downregulation of Mre11 at the mRNA and protein levels (Figure 5c) , which verified the model that Akt disrupts DSB repair through LEF1-dependent regulation of Mre11.
Analysis of the Mre11 promoter sequence revealed one potential LEF-1-binding site (CTTTGAT) (Figure 6a ). To determine whether the LEF-1 binding sequence in the Mre11 promoter can bind a b-catenin/ LEF-1 heterodimer, chromatin immunoprecipitation assay (ChIP) assay was employed. The result showed that the Mre11 genomic DNA promoter fragment (À1151 to À932) could be amplified by PCR in groups that used LEF-1 or b-catenin antibody to immunoprecipitate chromatin, indicating that b-catenin/LEF-1 heterodimer could directly bind to the promoter of Mre11 in vivo (Figure 6b ). To further examine the functional significance of this candidate LEF binding site, we also generated a mutant reporter pGL3-mtMre11 with the mutant sequence of LEF-1-binding conserved sequence, which rendered the LEF binding site in the Mre11 promoter inactive (Figure 6c) . The results showed that the luciferase activity of the pGL3-Mre11 increased up to 50% when HeLa cells were co-transfected with b-catenin plasmid, but the pGL3-mtMre11 abolished the induction of luciferase activity (Figure 6c ). We also tested the LEF-1 binding elements of the Mre11 promoter in isolation. The constructs containing four tandem copies of LEF-1 from the Mre11 promoter (pGL3-Lef) or containing four tandem copies of the mutant sequence of LEF-1-binding conserved sequence (pGL3-mtLef) were established (Figure 6d) . The results showed that the luciferase activity of the pGL3-Lef increased up to 50% when HeLa cells were co-transfected with b-catenin plasmid, but the increased luciferase activity decreased approximately 10-fold when HeLa cells were co-transfected with b-catenin and pGL3-mtLef (Figure 6d ). All these results suggested that b-catenin could upregulate the expression of Mre11 through LEF-1 binding to the promoter of Mre11 and inducing its activity.
Discussion
In this study, we confirmed the important roles of Akt and Mre11 during the process of DSB repair in cancer cells treated with IR. Inhibition of Akt activity impaired the repair of radiation-induced DNA-DSB damage in CNE2 cells, whereas activated Akt promoted the repair of radiation-induced DNA-DSB damage in HeLa cells. Knockdown of Mre11 also impaired the repair of radiation-induced DNA-DSB damage. More importantly, we found that Akt could regulate Mre11 expression, and GSK3b/b-catenin/LEF-1 pathway was involved in this process.
The radioresistance of cancers is one of major obstacles, which often leads to the failure of cancer therapy clinically. Numerous studies have shown that hyperactivation of Akt kinase is associated with However, we found that activated Akt could decrease the efficacy of radiation therapy through promoting DNA-DSB damage repair in this article. We observed inhibition of Akt activity impaired the repair of radiation-induced DNA-DSB damage in CNE2 cells, whereas activated Akt promoted the repair of radiationinduced DNA-DSB damage in HeLa cells (Figure 1) . These results were consistent with other recent studies which reported that activated Akt may decrease the efficacy of radiation therapy through promoting DNA repair in non-small-cell lung cancer cell lines and malignant-glioma cell lines (Tran et al., 2002; Kao et al., 2007; Toulany et al., 2008) . Together, all these indicate that Akt can modulate radiation-induced DNA-DSB damage repair, and can regulate the efficacy of radiation therapy in other types of human cancers in which Akt kinase is hyperactivated. Mre11, one of important DSB repair elements, is required for DNA-DSB repair including non-homologous end-joining repair system and homologous recombination repair system. Ding et al., 2006; Williams et al., 2007 Williams et al., , 2008 . It also can stabilize Rad50 and Nbs1 polypeptides and act as a chaperone for the MRN complex (Takemura et al., 2006) . In this study, we found that knockdown of Mre11 obviously impaired the repair of radiation-induced DNA-DSB damage in CNE2 and HeLa cells (Figure 2 ). As Mre11 can stabilize Rad50 and Nbs1, the num ber of MRN complexes decreased dramatically after Mre11 was knockdown. Accordingly, the number of MRN complexes binding to radiation-induced DNA double breaks obviously reduced, thus seriously affected the procedure of repair, leading to DNA double breaks unrepaired in CNE2 and HeLa cells. It also has been reported that when Mre11 was knocked down by siRNA, the cells were more sensitive to S-phase drugs, and more DNA double breaks were accumulated in cells (He et al., 2007) . Therefore, knockdown of Mre11 can radiosensitize in cancer cells through interfering DNA double break repair.
More important, our data uncovered that Akt might regulate Mre11 expression to promote DSB repair, and GSK3b/b-catenin/LEF-1 pathway was involved in this regulation. First, inhibition of phosphorylation of Akt by siRNA and LY294002 efficiently downregulated the Mre11 expression in CNE2 cells (Figures 3a and b) , whereas overexpression of activated myr-Akt1 plasmid upregulated the Mre11 expression in HeLa cells (Figure 3c ). Also, luciferase reporter assays showed that co-transfection of activated myr-Akt1 plasmid in CNE2 and HeLa cells obviously enhanced pGL3-Mre11 reporter activity, and this response could be suppressed by LY294002 (Figure 3e ). These results showed that Akt could regulate Mre11 expression at the transcriptional levels in cancer cells. Second, in these cell models, Akt might regulate b-catenin/LEF-1 pathway through GSK3b, as demonstrated by the levels of phosphoGSK3b and b-catenin decreased when the activity of Akt was inhibited by LY294002 in CNE2 cells (Figure 4a) , and the levels of phospho-GSK3b and b-catenin increased when constitutively activated Akt1 was overexpressed in HeLa cells (Figure 4b ). Third, b-catenin might regulate Mre11 expression through transcription factor LEF-1. In our experiments, knockdown of b-catenin or LEF-1 in CNE2 and HeLa/myrAkt1 cells led to the downregulation of Mre11 (Figures  5a and c) , whereas overexpression of b-catenin in HeLa cells led to the upregulation of Mre11 at the mRNA and protein levels (Figure 5b) . Furthermore, ChIP assay showed b-catenin/LEF-1 heterodimer could directly bind to the promoter of Mre11 in vivo (Figure 6b ). And the luciferase activity of the pGL3-Mre11 and pGL3-Lef increased obviously when HeLa cells were cotransfected with b-catenin plasmid, but was abolished when the LEF-1-binding conserved sequences of Mre11 promoter were mutated (Figures 6c and d) . All these results suggest that PKB/Akt can regulate the expression of Mre11 through GSK3b/b-catenin/LEF-1 pathway. When GSK-3b is inhibited by activated Akt, b-catenin escapes from phosphorylation. Unphosphorylated-b-catenin accumulates in the cytoplasm and translocates to the nucleus and binds with transcription factor LEF-1 to form b-catenin/LEF-1 heterodimer. Then this complex directly binds to the promoter of Mre11 and induces its activity, which leads to upregulation of Mre11 expression and promotes the process of DNA-DSB repair in cancer cells. However, we found that inhibition of Akt also impaired the repair of radiation-induced DNA-DSB damage in CNE2/Mre11 shRNA cells (Supplementary Figure S2) . After 24 h post-irradiation, the number of g-H2AX-positive cells in Mre11 shRNA group dropped to 30.23%, whereas in Mre11 shRNA þ LY294002 group remained at 43.32% (Po0.05). The possible reason is that Akt might promote the repair of DSB damage through other pathways, such as by inhibiting the activity of FOXO3a (Tran et al., 2002) or by phosphorylation of DNA-PKcs (Toulany et al., 2008) . Therfore, we consider that the repair of radiation-induced DNA-DSB damage by Mre11 is merely part of the role of Akt.
Indeed, the enhancement of DNA repair in cancer cells is one of the crucial factors resulting in cellular resistance to IR. Researchers have focused on DNArepair interference as an adjuvant approach for combating intrinsic or acquired tumor radioresistance (Ding et al., 2006) . Therefore, it is very important to examine the molecules that regulate DNA-repair pathways. In this study, we confirmed the important roles of Akt during the repair of radiation-induced DNA-DSB damage in cancer cells. Also, our results supported the notion that Mre11 might be a potent target of DNA-repair systems for radiosensitization. In addition, we found a new molecular mechanism of how Akt regulated repair of DSB and uncovered the relationship between Akt and Mre11. Activated Akt could upregulate the expression of Mre11 through GSK3b/b-catenin/ LEF-1 pathway, then promoted the repair of radiationinduced DSB damage. These principal findings favor Akt as an excellent target to enhance radiation toxicity in cancer cells and may thus help to develop new effective strategies to sensitize cancer cells to radiation therapy in which Akt kinase is hyperactivated.
Materials and methods

Cell culture and reagents
Human cervix cancer cell line HeLa and nasopharyngeal carcinoma cell line CNE 2 were cultivated in DMEM medium supplemented 10% fetal bovine serum in a 5% CO 2 humidified atmosphere at 37 1C. Anti-Akt, phospho-Akt1/2/3(Ser473), GSK3a/b and horseradish peroxidase-conjugated second antibodies were purchased from Santa Cruz Biotechnology (California, CA, USA). phospho-H2AX (g-H2AX), b-catenin, phospho-GSK3b, LEF-1, myc-tag, chemiluminescence reagents and 10 Â cell lysis buffer were obtained from Cell Singnaling (Beverly, MA, USA). Anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was purchased from KangChen biotechnology (ShangHai, China). Anti-Mre11 antibody was obtained from Novus Biologicals (Littleton, CO, USA). Dimethylsulfoxid and 4, 6-diamidine-2-phenylindole were purchased from Sigma (St Louis, MO, USA). TRIzol, Lipofectamine 2000, Goat anti-rabbit IgG (highly cross-adsorbed) Alexa Flour 488 antibody and Platinum Tag DNA Polymerase High Fidelity were obtained from Invitrogen Corporation (Carlsbad, CA, USA). pfuUltra High-Fidelity DNA Polymerase and DpnI were bought from Stratagene Corporation (La Jolla, CA, USA).
g-H2AX foci assay Cells were seeded into a 24-well plate covered with 13 mm Â 13 mm cover slips for 18-24 h, and then were X-ray irradiated. After treatment, the cells were fixed with PBS containing 4% parafornaldhyde for 20 min and permeabilized with 0.25% TritonX-100 in PBS for 10 min at room temperature. After being treated with blocking buffer (PBS þ 0.1%Tween 20 þ 1% bovine serum albumin) for 30 min, the cells were incubated with anti-g-H2AX antibody diluted in blocking buffer (1:400) overnight at 4 1C or 2-3 h at room temperature, then incubated with an Alexa Flour 488 antibody diluted in blocking buffer (1:400) for 1 h at room temperature. After counterstaining with 4, 6-diamidine-2-phenylindole, cells in cover slips were observed using confocal microscopy (Olympus, Tokyo, Japan). All treatment groups were then assessed for g-H2AX foci by sequential imaging through each nuclei using pImageTool software (developed by the Department of Dental Diagnostic Science at The University of Texas Health Science Center, San Antonio, TX, USA). Cells displaying 10 or more foci were counted as positive cells, and these cells were regarded as DNA damaged and unrepaired cells. This criterion of g-H2AX foci positive cell has been reported by Taneja et al. (2004) .
Clonogenic assay
Cells were seeded into 6-well plates at defined densities and were X-ray irradiated at different dose. After 7-14 days of incubation, cultures were fixed and stained. Colonies formed with more than 50 cells were scored as survivors. The surviving fraction (SF) is the colonies counted divided by the number of colonies plated with a correction for the plating efficiency.
Constructs, retroviral infection and transfection
For stable Akt1 siRNA expression or Mre11 siRNA expression, the retroviral vector (pSUPER RNAi. puro, a gift of Professor Musheng Zeng, Cancer Center, Sun Yat-sen University, Guangzhou, China) encoding hairpin RNA sequences was constructed. The hairpin RNA (shRNA) sequences against Akt1 (5 0 -GAGTTTGAGTACCTGAA GCT-3 0 (Irie et al., 2005) ) or against Mre11 (5 0 -GATGC CATTGAGGAATTAG-3 0 (Pichierri and Rosselli, 2004) ) were synthesized by Invitrogen Life Technologies Corporation (Shanghai, China) and cloned into the expression vector. VSV-pseudotyped vectors were produced by transfection of the VSV-GPG producer cell line with 5 mg DNA using Lipofectamine 2000 in a six-well plate. Retrovirus containing supernatants were collected at days 5-7 after transfection. Then CNE2 cells were infected with retrovirus-containing supernatants for three times. The positive cells stably expressing Akt1 shRNA or Mre11 shRNA were selected under puromycine (1 mg ml À1 ). For the generation of cell lines stably expressing myrAkt1 (tagged with Myc or His), HeLa cells were seeded into six-well plates the day before transfection. Transfection of myrAkt1 plasmid (Upstate Biotechnology Inc., Lake Placid, NY, USA) was performed with Lipofectamine 2000. After 48 h of transfection, the positive clones were selected under G418 (500 mg ml
À1
). The efficiency of myr-Akt1 transfection was detected by myc-tag antibody.
For transient transfection, the siRNAs against the sequence 5 0 -AAGGAGGG UUGGCUGCACAAA-3 0 of the human Akt1 mRNA (Kim et al., 2005) , the sequence 5 0 -GATGC CATTGAGGAATTAG-3 0 of the human Mre11 mRNA (Pichierri and Rosselli, 2004) , and the sequence 5 0 -AAACUG CUAAAUGACGAGGAC-3 0 of the human b-catenin mRNA (Hadjihannas et al., 2006) were synthesized by GenChem Corporation (Shanghai, China). Lef-1 siRNA (h) was obtained from Santa Cruz Biotechnology (sc-35804). The cells were seeded into six-well plates the day before transfection. Transfection of siRNA was performed with Lipofectamine 2000. At 24-48 h after transfection, the cells were used for western blotting assay or g-H2AX foci assay.
Western blot analysis
After treatment, cells were harvested and lysed in 1 Â cell lysis buffer (Cell Singnaling) adding 1 mM phenylmethanesulfonyl fluoride (PMSF) immediately before use. A volume of 25-40 mg of total proteins was separated by SDS-PAGE transferred to polyvinylidene difluoride (PVDF) membranes, and analyzed as previously described (Deng et al., 2009a) .
Semi-quantitative reverse transcription-PCR Total RNA was isolated by TRIzol according to the manufacturer's instructions. Reverse transcription-PCR was performed as previously described (Deng et al., 2006) . These primers for Mre11 (sense: 5 0 -TCAACTTTGGGAAACTTAT C-3 0 , antisense: 5 0 -GAAGGCTGCTGTCTTGTAG-3 0 ) were designed to generate a fragment of 577 bp. These primers for GAPDH (sense: 5 0 -CCACCCATGGCAAATTCCATGGCA-3 0 antisense: 5 0 -TCTAGACGGCAGGTCAGGTCCACC-3 0 ) were designed to generate a fragment of 588 bp as an internal control. The level of Mre11 expression was normalized to GAPDH using Image J software (developed by the National Institutes of Health, USA).
ChIP
ChIP was performed using the ChIP assay kit (Active Motif, Carlsbad, CA, USA) according to the manufacturer's instruction. Approximately 1 Â 10 7 HeLa stably expressed myr-Akt1 cells were lyzed. Immunoprecipitations were performed with b-catenin antibody, LEF-1 antibody, Flag antibody or normal IgG antibody (provided in ChIP assay kit). The primers spanning the LEF-1 site on the Mre11 promoter (À1151 to À932) were as follows: forward 5 0 -GAGACACCCTTGGA ATCA-3 0 and reverse 5 0 -GGGTAAGATCTGTG GTATAA-3 0 .
Reporter construction and Luciferase assay A fragment spanning from À1173 to þ 42 relative to the transcription start site of human Mre11 genomic sequence (GenBank accession no. AF303379) (Pitts et al., 2001 ) was produced by PCR using Platinum Tag DNA Polymerase High Fidelityhe (Invitrogen Corporation). The forward primer was 5 0 -CTAGGTACCCGGCTTTTCAGTCACCCAAT-3 0 and the reverse primer was 5 0 -CGAAAGCTTAGAACGGCGT CCGTTTCTC-3 0 . This fragment was inserted into the KPNI and HindIII sites of pGL3-basic vector (Promega Co., Madison, WI, USA) to generate a Mre11 luciferase reporter (pGL3-Mre11). To generate pGL3-mtMre11 plasmid, the mutated LEF-1 binding site at nucleotides À1069 and À1068 from AT to GC were constructed by PCR-based site directed mutagenesis by using the pGL3-Mre11 plasmid. The forward primer was 5 0 -TTCTTTG GC TCTCAAACTAAT-3 0 and the reverse primer was 3 0 -AAGAAACCGAGAGTTTGATTA-5 0 . pfuUltra High-Fidelity DNA Polymerase and DpnI (Stratagene Corporation) were used. To construct the four tandem repeats of pGL3-Lef and pGL3-mtLef, we dimerized olignucleotide cassettes containing two copies of LEF-1 binding conserved sequence from the promoter of Mre11 and cloned the products into pGL3-basic vector (for pGL3-Lef: 5 0 -TTTCTTTGA TTCTCATTTCTTTGATTCTCA-3 0 ; for pGL3-mtLef: 5 0 -TT TCTTT G GC TCTCATTTCTTTGGC TCTCA-3 0 ). These recombinant plasmids were confirmed by DNA sequencing. Cells were co-transfected with a luciferase reporter with other plasmids. At 24-48 h after transfection, the activity of reporters was evaluated with dual-Glo luciferase assay system (Promega). The levels of firefly luciferase activity were normalized to pRL-TK luciferase activity.
Statistical analysis
The Student's t test was used to evaluate the statistical significance of the result at the 95% confidence level; a P value less than 0.05 was considered to indicate statistical significance.
